Immediate Impact
3 from Science/Nature 56 standout
Citing Papers
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
2019 Standout
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
2018 Standout
Works of A. Lakhani being referenced
High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities
2003
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| A. Lakhani | 166 | 163 | 108 | 16 | 344 | |
| Chantal Brouzes | 161 | 112 | 69 | 22 | 382 | |
| Michihiko Masuda | 170 | 107 | 79 | 26 | 362 | |
| G. P. Clein | 112 | 122 | 100 | 12 | 388 | |
| Ant Uzay | 235 | 85 | 96 | 21 | 410 | |
| Bjarne Bach Pedersen | 235 | 126 | 109 | 14 | 377 | |
| S Morandi | 174 | 142 | 88 | 21 | 306 | |
| Cristina Andrizzi | 144 | 158 | 107 | 12 | 394 | |
| D. K. Hossfeld | 198 | 128 | 66 | 22 | 402 | |
| Peter Meeus | 116 | 168 | 121 | 20 | 374 | |
| Sheryl L. Asplund | 87 | 115 | 154 | 15 | 324 |
All Works
Login with ORCID to disown or claim papers
Loading papers...